Cargando…

An integrated pan‐cancer analysis of TFAP4 aberrations and the potential clinical implications for cancer immunity

Studies have shown that transcription factor activating enhancer binding protein 4 (TFAP4) plays a vital role in multiple types of cancer; however, the TFAP4 expression profile is still unknown, as is its value within the human pan‐cancer analysis. The present study comprehensively analysed TFAP4 ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jian‐Nan, Kong, Xiang‐Shuo, Sun, Ping, Wang, Rui, Li, Wang, Chen, Qi‐Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882993/ https://www.ncbi.nlm.nih.gov/pubmed/33373169 http://dx.doi.org/10.1111/jcmm.16147

Ejemplares similares

Clinical Implications of Aberrant PD-1 and CTLA4 Expression for Cancer Immunity and Prognosis: A Pan-Cancer Study
por: Liu, Jian-Nan, et al.
Publicado: (2020)

An integrative pan cancer analysis of RET aberrations and their potential clinical implications
por: Zhou, Lei, et al.
Publicado: (2022)

Integrative pan-cancer analysis of MEK1 aberrations and the potential clinical implications
por: Zhou, Zhiyang, et al.
Publicado: (2021)

Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan‐cancer analysis
por: Liu, Haijing, et al.
Publicado: (2020)

The aberrant expression of rhythm genes affects the genome instability and regulates the cancer immunity in pan‐cancer
por: Zhou, Jian, et al.
Publicado: (2020)

Spectrum of BRAF Aberrations and Its Potential Clinical Implications: Insights From Integrative Pan-Cancer Analysis
por: Yi, Qiaoli, et al.
Publicado: (2022)

Pan-Cancer Integrated Analysis of HSF2 Expression, Prognostic Value and Potential Implications for Cancer Immunity
por: Chen, Fei, et al.
Publicado: (2022)

Transcriptional Regulation of the GPX1 Gene by TFAP2C and Aberrant CpG Methylation in Human Breast Cancer
por: Kulak, Mikhail V., et al.
Publicado: (2012)

Pan-cancer analysis of ASB3 and the potential clinical implications for immune microenvironment of glioblastoma multiforme
por: Mu, Long, et al.
Publicado: (2022)

Aberrant expression of WDR4 affects the clinical significance of cancer immunity in pan-cancer
por: Zeng, Hanqian, et al.
Publicado: (2021)

Distinct Activities of Tfap2A and Tfap2B in the Specification of GABAergic Interneurons in the Developing Cerebellum
por: Zainolabidin, Norliyana, et al.
Publicado: (2017)

Spectrum of BRCA1 interacting helicase 1 aberrations and potential prognostic and therapeutic implication: a pan cancer analysis
por: Long, Guo, et al.
Publicado: (2023)

Pan-cancer analysis of FBXW family with potential implications in prognosis and immune infiltration
por: Huang, Tingting, et al.
Publicado: (2022)

The methylation level of TFAP2A is a potential diagnostic biomarker for retinoblastoma: an analytical validation study
por: Zeng, Qi, et al.
Publicado: (2021)

Fragile Gene WWOX Guides TFAP2A/TFAP2C-Dependent Actions Against Tumor Progression in Grade II Bladder Cancer
por: Kołat, Damian, et al.
Publicado: (2021)

Functional Divergence of Mammalian TFAP2a and TFAP2b Transcription Factors for Bidirectional Sleep Control
por: Hu, Yang, et al.
Publicado: (2020)

Systematic Analysis of the Aberrances and Functional Implications of Ferroptosis in Cancer
por: Liu, Zekun, et al.
Publicado: (2020)

An Integrated Pan-Cancer Analysis of ADAMTS12 and Its Potential Implications in Pancreatic Adenocarcinoma
por: Song, Caiyun, et al.
Publicado: (2022)

Corrigendum: Fragile Gene WWOX Guides TFAP2A/TFAP2C-Dependent Actions Against Tumor Progression in Grade II Bladder Cancer
por: Kołat, Damian, et al.
Publicado: (2021)

MicroRNA-608 Promotes Apoptosis in Non-Small Cell Lung Cancer Cells Treated With Doxorubicin Through the Inhibition of TFAP4
por: Wang, Yi-Fei, et al.
Publicado: (2019)

Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genes
por: Orso, Francesca, et al.
Publicado: (2010)

Oncogenic LINC00857 recruits TFAP2C to elevate FAT1 expression in gastric cancer
por: Zhang, Wenqing, et al.
Publicado: (2022)

Integrated pan-cancer analysis of CSMD2 as a potential prognostic, diagnostic, and immune biomarker
por: Zhang, Huiyun, et al.
Publicado: (2022)

Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis
por: Zhang, Xu-dong, et al.
Publicado: (2023)

Clinical Implications of Necroptosis Genes Expression for Cancer Immunity and Prognosis: A Pan-Cancer Analysis
por: Li, Xin-yu, et al.
Publicado: (2022)

Alternative TFAP2A isoforms have distinct activities in breast cancer
por: Berlato, Chiara, et al.
Publicado: (2011)

TFAP4 promotes the growth of prostate cancer cells by upregulating FOXK1
por: Gu, Yuan, et al.
Publicado: (2021)

Corrigendum: MicroRNA-608 Promotes Apoptosis in Non-Small Cell Lung Cancer Cells Treated With Doxorubicin Through the Inhibition of TFAP4
por: Wang, Yi-Fei, et al.
Publicado: (2021)

TFAP2B mutation and dental anomalies
por: Tanasubsinn, Natchaya, et al.
Publicado: (2017)

Pan-cancer analysis of LncRNA XIST and its potential mechanisms in human cancers
por: Han, Wei, et al.
Publicado: (2022)

Chromatin accessibility analysis reveals that TFAP2A promotes angiogenesis in acquired resistance to anlotinib in lung cancer cells
por: Zhang, Le-le, et al.
Publicado: (2020)

TFAP2A potentiates lung adenocarcinoma metastasis by a novel miR-16 family/TFAP2A/PSG9/TGF-β signaling pathway
por: Xiong, Yanlu, et al.
Publicado: (2021)

Pan-cancer analysis of DNA methyltransferase family with potential implications in prognosis and immunology in human cancer
por: Ding, Jiayu, et al.
Publicado: (2022)

FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
por: Cai, Jiayang, et al.
Publicado: (2022)

TfAP-2 is required for night sleep in Drosophila
por: Kucherenko, Mariya M., et al.
Publicado: (2016)

Aberrant PRDM9 expression impacts the pan-cancer genomic landscape
por: Houle, Armande Ang, et al.
Publicado: (2018)

Pan-cancer predictions of transcription factors mediating aberrant DNA methylation
por: Detilleux, Dylane, et al.
Publicado: (2022)

Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment
por: Li, Juanni, et al.
Publicado: (2021)

Integrative Analysis of Hypoxia-Associated Signature in Pan-Cancer
por: Zhang, Qian, et al.
Publicado: (2020)

Comprehensive Analysis of Prognostic Value and Immune Infiltration of TFAP2 Family Members in Bladder Cancer from Database and FFPE Sample
por: Yuan, Feng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i26pt6rauono23q3fc1k0ri02e